Diseases

Displaying entries 51 - 75 of 149 in total
Protein Name Gene Name Uniprot ID Disease Name References
Metalloproteinase inhibitor 2 Timp2 P25785 Parkinson Disease Lorenzl, S. et al. (Neurochem Int, 2003)
Metalloproteinase inhibitor 2 Timp2 P30121 Parkinson Disease Lorenzl, S. et al. (Neurochem Int, 2003)
Natriuretic peptides B Nppb P40753 Parkinson Disease Watanabe, H. et al. (Neurology, 2009)
Lipopolysaccharide-binding protein Lbp Q61805 Parkinson Disease Hasegawa, S. et al. (PLoS One, 2015)
Interleukin-1 receptor antagonist protein Il1rn P25085 Parkinson Disease Arman, A. et al. (Eur Cytokine Netw, 2010)
Interleukin-1 receptor antagonist protein Il1rn P25086 Parkinson Disease Arman, A. et al. (Eur Cytokine Netw, 2010)
Neurotrophin-3 Ntf3 P20181 Parkinson Disease
Cytoplasmic aconitate hydratase Aco1 P28271 Parkinson Disease Faucheux, B. A. et al. (J Neurochem, 2002)
Interleukin-10 Il10 P29456 Parkinson Disease
Brain-derived neurotrophic factor Bdnf P21237 Parkinson Disease
Howells, D. W. et al. (Exp Neurol, 2000), Momose, Y. et al. (Ann Neurol, 2002), Guillin, O. et al. (Eur J Pharmacol, 2003), Hong, C. J. et al. (Neurosci Lett, 2003), Parsian, A. et al. (Parkinsonism Relat Disord, 2004), Liu, Q. R. et al. (Am J Med Genet B Neuropsychiatr Genet, 2005), Foltynie, T. et al. (J Neurol, 2005), Nishimura, M. et al. (Mov Disord, 2005), Zintzaras, E. et al. (J Hum Genet, 2005), Karamohamed, S. et al. (Neurology, 2005), Saarela, M. S. et al. (Folia Neuropathol, 2006), Akatsu, H. et al. (Dement Geriatr Cogn Disord, 2006), Xiromerisiou, G. et al. (Neurosci Lett, 2007), Chen, C. M. et al. (Am J Med Genet B Neuropsychiatr Genet, 2007), Altar, C. A. et al. (Neuropsychopharmacology, 2009), Foltynie, T. et al. (J Neurol Neurosurg Psychiatry, 2009), Tong, M. et al. (J Alzheimers Dis, 2009), Zuccato, C. et al. (Nat Rev Neurol, 2009), Guerini, F. R. et al. (Eur J Neurol, 2009), Gao, L. et al. (Acta Neurol Scand, 2010), Fishman-Jacob, T. et al. (Neurodegener Dis, 2010), Somoza, R. et al. (Biol Blood Marrow Transplant, 2010), Lin, C. H. et al. (Parkinsonism Relat Disord, 2011), Chen, L. et al. (Biochem Biophys Res Commun, 2011), Toulouse, A. et al. (Neurotox Res, 2012), Liu, J. et al. (Parkinsonism Relat Disord, 2012), Karakasis, C. et al. (J Clin Neurosci, 2011), Lauterbach, E. C. (Prog Neuropsychopharmacol Biol Psychiatry, 2012), Fu, A. et al. (PLoS One, 2013), Dai, L. et al. (Int J Neurosci, 2013), Sun, X. L. et al. (Mol Neurobiol, 2014), Cheshire, P. et al. (Neurodegener Dis, 2014), Svetel, M. et al. (Eur Neurol, 2013), Lee, Y. H. et al. (J Mot Behav, 2014), Fenner, M. E. et al. (J Mol Histol, 2014), Bialecka, M. et al. (Neurosci Lett, 2014), Kaplan, N. et al. (J Mol Neurosci, 2014), Berg, J. et al. (Stem Cell Rev Rep, 2015), Mariani, S. et al. (Rejuvenation Res, 2015), van der Kolk, N. M. et al. (Neurobiol Aging, 2015), Altmann, V. et al. (Neurosci Lett, 2016), Cagni, F. C. et al. (J Neuropsychiatry Clin Neurosci, 2017), Kang, S. S. et al. (Proc Natl Acad Sci U S A, 2017), Yoshimoto, Y. et al. (Brain Res, 1995)
Myelin protein P0 Mpz P06907 Parkinson Disease
Granulin precursor GRN M3YD29 Parkinson Disease
Granulins Grn P28798 Parkinson Disease
CCN family member 2 Ccn2 Q9R1E9 Parkinson Disease McClain, J. A. et al. (Neurosci Lett, 2009)
CCN family member 2 Ccn2 Q53YJ0 Parkinson Disease McClain, J. A. et al. (Neurosci Lett, 2009)
Peroxiredoxin-5, mitochondrial Prdx5 P99029 Parkinson Disease De Simoni, S. et al. (Neurosci Lett, 2008)
Peroxiredoxin-5, mitochondrial Prdx5 Q9R063 Parkinson Disease De Simoni, S. et al. (Neurosci Lett, 2008)
Phosphatidylethanolamine-binding protein 1 Pebp1 P70296 Parkinson Disease Wen, Z. et al. (Neurobiol Aging, 2014)
Phosphatidylethanolamine-binding protein 1 Pebp1 P31044 Parkinson Disease Wen, Z. et al. (Neurobiol Aging, 2014)
Peroxiredoxin-2 Prdx2 Q61171 Parkinson Disease Fang, J. et al. (Proc Natl Acad Sci U S A, 2007), Hu, X. et al. (J Neurosci, 2011)
Peroxiredoxin-2 Prdx2 P35704 Parkinson Disease Fang, J. et al. (Proc Natl Acad Sci U S A, 2007), Hu, X. et al. (J Neurosci, 2011)
Peroxiredoxin-2 Prdx2 Q6PDV3 Parkinson Disease Fang, J. et al. (Proc Natl Acad Sci U S A, 2007), Hu, X. et al. (J Neurosci, 2011)
Alpha-L-iduronidase Idua P48441 Parkinson Disease Narahara, M. et al. (PLoS One, 2014)
Glial cell line-derived neurotrophic factor Gdnf P48540 Parkinson Disease
Latchman, D. S. et al. (Mov Disord, 2000), Deglon, N. et al. (Hum Gene Ther, 2000), Bauer, M. et al. (Hum Gene Ther, 2000), Bohn, M. C. et al. (Int J Dev Neurosci, 2000), Kozlowski, D. A. et al. (Exp Neurol, 2000), Eberhardt, O. et al. (J Neurosci, 2000), Ozawa, K. et al. (J Neural Transm Suppl, 2000), During, M. J. et al. (Hum Gene Ther, 2001), Date, I. et al. (Cell Transplant, 2001), Hurelbrink, C. B. et al. (Expert Opin Pharmacother, 2001), Arenas, E. (Brain Res Bull, 2002), McGrath, J. et al. (Cell Transplant, 2002), Dillon-Carter, O. et al. (Cell Transplant, 2002), Sanchez, B. et al. (Brain Res Mol Brain Res, 2002), Kordower, J. H. (Ann Neurol, 2003), Chen, X. et al. (Parkinsonism Relat Disord, 2003), Maruyama, W. et al. (Neurochem Int, 2004), Lo Bianco, C. et al. (Neurobiol Dis, 2004), Duan, D. et al. (Exp Brain Res, 2005), Muramatsu, S. et al. (Expert Opin Biol Ther, 2005), Dowd, E. et al. (Eur J Neurosci, 2005), Ericson, C. et al. (Eur J Neurosci, 2005), Eslamboli, A. (Rev Neurosci, 2005), Backman, C. M. et al. (Mol Cell Endocrinol, 2006), Jain, S. et al. (J Neurosci, 2006), Gasmi, M. et al. (Mol Ther, 2007), Tatarewicz, S. M. et al. (J Clin Immunol, 2007), Ebert, A. D. et al. (Exp Neurol, 2008), Xia, C. F. et al. (J Gene Med, 2008), Lucking, C. B. et al. (Neurobiol Aging, 2010), Deierborg, T. et al. (Prog Neurobiol, 2008), Eberling, J. L. et al. (Hum Gene Ther, 2009), Herzog, C. D. et al. (Neurosurgery, 2009), Yang, X. et al. (J Gene Med, 2009), Manfredsson, F. P. et al. (Curr Gene Ther, 2009), Alladi, P. A. et al. (J Chem Neuroanat, 2010), Manfredsson, F. P. et al. (Discov Med, 2010), Souza, R. P. et al. (Psychopharmacology (Berl), 2010), Yasuda, T. et al. (Expert Rev Neurother, 2010), Glavaski-Joksimovic, A. et al. (J Neurosci Res, 2010), Laganiere, J. et al. (J Neurosci, 2010), Pascual, A. et al. (J Mol Endocrinol, 2011), Decressac, M. et al. (Brain, 2011), Mickiewicz, A. L. et al. (CNS Neurol Disord Drug Targets, 2011), Kells, A. P. et al. (Neurobiol Dis, 2012), Drinkut, A. et al. (Mol Ther, 2012), Tai, K. et al. (PLoS One, 2012), Hickey, P. et al. (Expert Opin Biol Ther, 2013), Kordower, J. H. et al. (Mov Disord, 2013), Quintino, L. et al. (Mol Ther, 2013), Redmond, D. E. Jr et al. (Mol Ther, 2013), Sun, X. L. et al. (Mol Neurobiol, 2014), Deng, X. et al. (PLoS One, 2013), Kotyuk, E. et al. (PLoS One, 2013), Klein, P. et al. (EMBO J, 2014), Lu-Nguyen, N. B. et al. (Hum Gene Ther, 2014), Jeong, K. H. et al. (J Med Food, 2015), Smith, R. C. et al. (Exp Neurol, 2015), Domanskyi, A. et al. (Hum Gene Ther, 2015), Kordower, J. H. (Methods Mol Biol, 2016), Lindholm, D. et al. (Cell Mol Life Sci, 2016), Kumar, A. et al. (PLoS Genet, 2015), Dong, J. et al. (CNS Neurosci Ther, 2016), Espadas-Alvarez, A. J. et al. (Nanomedicine, 2017), Lin, L. F. et al. (Science, 1993), Choi-Lundberg, D. L. et al. (Science, 1997), Hunot, S. et al. (J Neural Transm (Vienna), 1996), Mandel, R. J. et al. (Proc Natl Acad Sci U S A, 1997), Lapchak, P. A. et al. (Brain Res, 1997), Walker, D. G. et al. (Brain Res, 1998), Wartiovaara, K. et al. (Exp Neurol, 1998), Choi-Lundberg, D. L. et al. (Exp Neurol, 1998), Bohn, M. C. (Biochem Pharmacol, 1999)
Adapter molecule crk Crk Q64010 Parkinson Disease